Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Sickle Cell Disease: Managing Pain
source: National heart, lung and blood institute
year: 2018
summary/abstract:Currently, sickle cell disease has no widely available cure. However, if you have the disease, certain treatments can help with your pain.
Good health care is important for people who have sickle cell disease, so see your doctor regularly. Work with your doctor to create a pain control plan that makes sense for you, and carry it with you if you go to the emergency room.
· Mild pain is often treated at home. More severe pain may need to be treated in a clinic or hospital.
· Fluids can help prevent dehydration, which can worsen pain.
· Over-the-counter pain medicine can help with mild to moderate pain.
· Stronger medicines called opioids may be prescribed for more severe pain.
· Ask your doctor about a medicine called hydroxyurea that may decrease pain episodes. Some patients may benefit from taking a new medicine called L-glutamine oral powder. Talk to your doctor to determine if this medicine is right for you.
· Other methods for managing pain include getting physical therapy, using a heating pad, or engaging in activities, such as listening to music, that help distract you from the pain.
read moreRelated Content
-
Mechanisms of Pain in Sickle Cell DiseaseObjectives: The hallmark of sickle cell...
-
Sickle cell advocate wins fight for high-dose opioidsGeorge H. Carter appears to have won h...
-
Prevention of acute sickle cell crisis: review of the NEJM reportA recent article in the New England Jour...
-
SCDAA Teams with MedicAlert Foundation to Improve Emergency Outcomes During Sickle Cell Crises[Hanover, Md., June 26, 2023] – The Si...
-
Vaso occlusive Crisis Pain Assessment & Managementhttps://www.youtube.com/watch?time_conti...
-
Safety and early hints of benefit seen in phase 1b trial of PF-04447943Sickle cell disease (SCD) patients were ...
-
GBT expands sickle cell disease pipeline with worldwide licensing agreement for inclacumab for the treatment of vaso...Global Blood Therapeutics, Inc...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.